icrf 193 has been researched along with Granulocytic Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bukowski, RM; Chikamori, K; Ganapathi, MK; Ganapathi, R; Grabowski, DR; Grozav, AG; Gudkov, AV; Hill, JE; Rybicki, LR; Tanimoto, M; Vaziri, SA; Wang, J; Yen, A; Zarkhin, E | 1 |
1 other study(ies) available for icrf 193 and Granulocytic Leukemia
Article | Year |
---|---|
Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest.
Topics: Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Division; Diketopiperazines; DNA Topoisomerases, Type II; DNA-Binding Proteins; Down-Regulation; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Leukemic; Heat-Shock Proteins; HL-60 Cells; Humans; Leukemia, Myeloid; Peroxidases; Peroxiredoxins; Piperazines; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Topoisomerase II Inhibitors; Tretinoin | 2006 |